Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
批准号:
7731970
负责人:
Jack A Elias
金额:
$41.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2013-06-30
关键词:
AddressAdverse effectsAgonistAirAlveolarAntiviral AgentsApoptosisApoptoticCell DeathChildChronic Obstructive Airway DiseaseCigaretteDifferentiation AntigensDiseaseDouble-Stranded RNAEndoribonucleasesEnvironmental Tobacco SmokeEpithelialEpithelial CellsEukaryotic Initiation Factor-2Eukaryotic Initiation FactorsEventGenesGeneticImmuneImmune responseIndividualInfectionInflammationInflammatoryInfluenzaInjuryInterferonsInterleukin-18LaboratoriesLiteratureLocationLungMediatingMusNatural ImmunityPathogenesisPathologicPathway interactionsPatientsPlayPoly I-CPulmonary EmphysemaRespiratory Syncytial Virus InfectionsRespiratory physiologyRespiratory syncytial virusRibonucleasesRoleSeveritiesSmokeSmokerStem cellsStructure of respiratory epitheliumSystemTestingTissuesTretinoinViralVirusVirus Diseasesbasecell injurycigarette smoke-inducedcigarette smokingcigarette smokingcytokinedefined contributioneIF-2 Kinaseendoribonucleaseexpectationhelicaseinfluenzavirusmacrophagemelanomamortalityoligoadenylateprogenitorpublic health relevancereceptorrepairedresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Viral infections have more severe consequences in patients exposed to cigarette smoke (CS) than in non/never-exposed individuals. This is seen in smokers with COPD. It is also seen in otherwise healthy, influenza-infected smokers and respiratory syncytial virus-infected children exposed to second hand smoke. We compared the innate immune responses in mice exposed to room air (RA) or CS. CS enhanced the inflammatory, apoptotic and remodeling responses that were induced by Poly(I:C) (a viral innate immunity agonist or PAMP) and influenza virus. These responses were: (a) mediated by the RIG-like helicase (RLH) antiviral pathway, (b) mediated by an effector cascade that is downstream of RLH and includes type I and II Interferons, IL-18, double-Stranded RNA-Dependent Protein Kinase (PKR) and eukaryotic initiation factor-2( (eIF2() and (c) associated with activation of the 2',5'-oligoadenylate synthase (OAS)/endoribonuclease L (RNaseL) antiviral pathway. Importantly, mice that had been exposed to CS manifest a Sca1+ epithelial cell repair response that was blunted by treatment with viruses/viral PAMPs. This led to the following multipart hypothesis. Hypothesis 1. CS augments RLH-mediated innate responses against viruses/viral PAMPs in the lung. 2. This exaggerated response is centered in the respiratory epithelium and plays a major role in the inflammation and remodeling caused by CS plus viruses/viral PAMPs. 3. The exaggerated alveolar remodeling that in mice exposed to CS and viruses/viral PAMPS is the result of the ability of RLH innate immune activation to activate both the PKR/eIF2( and the 2',5'OAS/RNase L antiviral systems to simultaneously induce epithelial injury and inhibit progenitor cell-based repair responses. Specific Aims. To test this hypothesis we propose to: 1. Define the helicases that mediate the effects of viruses/viral PAMPs in CS-exposed mice. 2. Define the role(s) of epithelial and macrophage RLH-mediated innate responses in the pathogenesis of the effects of CS plus viruses/viral PAMPs. 3. Define the mechanism by which RLH activation regulates epithelial cell injury/apoptosis in mice exposed to CS plus virus/viral PAMPs. 4. Define the mechanism by which RLH-mediated innate activation regulates progenitor cell based repair responses in mice exposed to CS plus virus/viral PAMPs. PUBLIC HEALTH RELEVANCE: Our studies demonstrate that cigarette smoke enhances antiviral innate immune pulmonary responses that contribute to pathologic inflammation and emphysema. The present studies will further define the receptors that mediate these responses, their tissue locations and the mechanisms of these critical interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differential Roles of Chi3l1 and its receptors in COPD and IPF
-
批准号:10172313
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2013
-
负责人:Jack A Elias
-
依托单位:
Differential Roles of Chi3l1 and its receptors in COPD and IPF
-
批准号:10636903
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2013
-
负责人:Jack A Elias
-
依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
-
批准号:8499409
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2011
-
负责人:Jack A Elias
-
依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
-
批准号:8320196
-
项目类别:
-
资助金额:$65.81万
-
财政年份:2011
-
负责人:Jack A Elias
-
依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
-
批准号:8818109
-
项目类别:
-
资助金额:$63.38万
-
财政年份:2011
-
负责人:Jack A Elias
-
依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
-
批准号:8138083
-
项目类别:
-
资助金额:$66.2万
-
财政年份:2011
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:7783229
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:8402992
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:8015265
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:8789047
-
项目类别:
-
资助金额:$15.68万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:8207985
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
AMCase and BRP-39 in Th2 Inflammation and Asthma
-
批准号:7474751
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
AMCase and BRP-39 in Th2 Inflammation and Asthma
-
批准号:7124655
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Preotease/Cathepsin-Mediated Apoptosis in COPD
-
批准号:7251993
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Preotease/Cathepsin-Mediated Apoptosis in COPD
-
批准号:6966981
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
AMCase and BRP-39 in Th2 Inflammation and Asthma
-
批准号:7272691
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Preotease/Cathepsin-Mediated Apoptosis in COPD
-
批准号:7450972
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
-
批准号:7907801
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
AMCase and BRP-39 in Th2 Inflammation and Asthma
-
批准号:6960185
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
-
批准号:8293312
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
海外基金